Brought to you by 
WuXi PharmaTech completes $156mm IPO on NYSE
13 Nov 2007
Executive Summary
Chinese CRO WuXi PharmaTech has netted $155.9mm in its IPO on the NYSE by selling about 12mm American Depository Shares--including the overallotment--at $14 apiece (above its proposed $11-13 range); selling shareholders issued an additional 3.2mm ADSs.
Deal Industry
- Biotechnology
- Contract Research, Toxicology Testing-CRO
- Pharmaceuticals
- Services
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
WuXi PharmaTech completes $156mm IPO on NYSE
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice